Cranial reconstruction using allogeneic mesenchymal stromal cells: A phase 1 first-in-human trial

David Anthony Morrison, Alan Matthew Kop, Anastasia Nilasaroya, Marian Sturm, Kathryn Shaw, Stephen Honeybul

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cranioplasty is necessary for patients that have undergone craniectomy following trauma, stroke or other causes of elevated intracranial pressure. This study assessed the effectiveness of treating cranial defects with allogeneic mesenchymal stromal cells (MSC) on a ceramic carrier and polymer scaffold, to produce viable bone and healing of a cranial void. Patients underwent a baseline computed tomography (CT) scan for construct design. Two sets of interlocking moulds were three-dimensional printed to enable shaping of two polymer meshes, which formed the boundaries of the construct corresponding to restoration of the skull interna and externa. In vitro expanded donor MSC were seeded onto ceramic granules in a good manufacturing practices facility. The inner mesh was placed in theatre, followed by the cell-loaded granules, and the outer mesh. Patients were followed-up at 3, 6 and 12 months and cosmesis assessed visually, while bone formation was assessed by CT scans at 1 day, 3 months and 12 months. Manufacture of the construct and surgery was uneventful for all three patients. Initial cosmesis was excellent with no complications. New bone formation was demonstrated by analysis of CT data; however, bone resorption was noted in all 3 cases on the 12-month CT scan. The lack of rigidity of the construct in an environment with continuous pulsatile movement may be preventing the formation of solid bone. It is possible to produce a customized allogeneic MSC construct for cranial reconstruction to replace cranial bone with good cosmesis, using a combination of medical computer modelling, rapid-prototyping and tissue engineering.

Original languageEnglish
Pages (from-to)341-348
Number of pages8
JournalJournal of Tissue Engineering and Regenerative Medicine
Volume12
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Fingerprint

Mesenchymal Stromal Cells
Bone
Tomography
Osteogenesis
Ceramics
Polymers
Bone and Bones
Intracranial Hypertension
Tissue Engineering
Bone Resorption
Skull
Fungi
Theaters
Stroke
Tissue Donors
Rapid prototyping
Tissue engineering
Scaffolds
Rigidity
Surgery

Cite this

Morrison, David Anthony ; Kop, Alan Matthew ; Nilasaroya, Anastasia ; Sturm, Marian ; Shaw, Kathryn ; Honeybul, Stephen. / Cranial reconstruction using allogeneic mesenchymal stromal cells : A phase 1 first-in-human trial. In: Journal of Tissue Engineering and Regenerative Medicine. 2018 ; Vol. 12, No. 2. pp. 341-348.
@article{2850c9f74f814b3187e75f772cce6542,
title = "Cranial reconstruction using allogeneic mesenchymal stromal cells: A phase 1 first-in-human trial",
abstract = "Cranioplasty is necessary for patients that have undergone craniectomy following trauma, stroke or other causes of elevated intracranial pressure. This study assessed the effectiveness of treating cranial defects with allogeneic mesenchymal stromal cells (MSC) on a ceramic carrier and polymer scaffold, to produce viable bone and healing of a cranial void. Patients underwent a baseline computed tomography (CT) scan for construct design. Two sets of interlocking moulds were three-dimensional printed to enable shaping of two polymer meshes, which formed the boundaries of the construct corresponding to restoration of the skull interna and externa. In vitro expanded donor MSC were seeded onto ceramic granules in a good manufacturing practices facility. The inner mesh was placed in theatre, followed by the cell-loaded granules, and the outer mesh. Patients were followed-up at 3, 6 and 12 months and cosmesis assessed visually, while bone formation was assessed by CT scans at 1 day, 3 months and 12 months. Manufacture of the construct and surgery was uneventful for all three patients. Initial cosmesis was excellent with no complications. New bone formation was demonstrated by analysis of CT data; however, bone resorption was noted in all 3 cases on the 12-month CT scan. The lack of rigidity of the construct in an environment with continuous pulsatile movement may be preventing the formation of solid bone. It is possible to produce a customized allogeneic MSC construct for cranial reconstruction to replace cranial bone with good cosmesis, using a combination of medical computer modelling, rapid-prototyping and tissue engineering.",
keywords = "allogeneic cells, clinical trial, cranial reconstruction, cranioplasty, mesenchymal stromal cells, tissue engineering",
author = "Morrison, {David Anthony} and Kop, {Alan Matthew} and Anastasia Nilasaroya and Marian Sturm and Kathryn Shaw and Stephen Honeybul",
year = "2018",
month = "2",
day = "1",
doi = "10.1002/term.2459",
language = "English",
volume = "12",
pages = "341--348",
journal = "Journal of Tissue Engineering and Regenerative Medicine",
issn = "1932-6254",
publisher = "John Wiley & Sons",
number = "2",

}

Cranial reconstruction using allogeneic mesenchymal stromal cells : A phase 1 first-in-human trial. / Morrison, David Anthony; Kop, Alan Matthew; Nilasaroya, Anastasia; Sturm, Marian; Shaw, Kathryn; Honeybul, Stephen.

In: Journal of Tissue Engineering and Regenerative Medicine, Vol. 12, No. 2, 01.02.2018, p. 341-348.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cranial reconstruction using allogeneic mesenchymal stromal cells

T2 - A phase 1 first-in-human trial

AU - Morrison, David Anthony

AU - Kop, Alan Matthew

AU - Nilasaroya, Anastasia

AU - Sturm, Marian

AU - Shaw, Kathryn

AU - Honeybul, Stephen

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Cranioplasty is necessary for patients that have undergone craniectomy following trauma, stroke or other causes of elevated intracranial pressure. This study assessed the effectiveness of treating cranial defects with allogeneic mesenchymal stromal cells (MSC) on a ceramic carrier and polymer scaffold, to produce viable bone and healing of a cranial void. Patients underwent a baseline computed tomography (CT) scan for construct design. Two sets of interlocking moulds were three-dimensional printed to enable shaping of two polymer meshes, which formed the boundaries of the construct corresponding to restoration of the skull interna and externa. In vitro expanded donor MSC were seeded onto ceramic granules in a good manufacturing practices facility. The inner mesh was placed in theatre, followed by the cell-loaded granules, and the outer mesh. Patients were followed-up at 3, 6 and 12 months and cosmesis assessed visually, while bone formation was assessed by CT scans at 1 day, 3 months and 12 months. Manufacture of the construct and surgery was uneventful for all three patients. Initial cosmesis was excellent with no complications. New bone formation was demonstrated by analysis of CT data; however, bone resorption was noted in all 3 cases on the 12-month CT scan. The lack of rigidity of the construct in an environment with continuous pulsatile movement may be preventing the formation of solid bone. It is possible to produce a customized allogeneic MSC construct for cranial reconstruction to replace cranial bone with good cosmesis, using a combination of medical computer modelling, rapid-prototyping and tissue engineering.

AB - Cranioplasty is necessary for patients that have undergone craniectomy following trauma, stroke or other causes of elevated intracranial pressure. This study assessed the effectiveness of treating cranial defects with allogeneic mesenchymal stromal cells (MSC) on a ceramic carrier and polymer scaffold, to produce viable bone and healing of a cranial void. Patients underwent a baseline computed tomography (CT) scan for construct design. Two sets of interlocking moulds were three-dimensional printed to enable shaping of two polymer meshes, which formed the boundaries of the construct corresponding to restoration of the skull interna and externa. In vitro expanded donor MSC were seeded onto ceramic granules in a good manufacturing practices facility. The inner mesh was placed in theatre, followed by the cell-loaded granules, and the outer mesh. Patients were followed-up at 3, 6 and 12 months and cosmesis assessed visually, while bone formation was assessed by CT scans at 1 day, 3 months and 12 months. Manufacture of the construct and surgery was uneventful for all three patients. Initial cosmesis was excellent with no complications. New bone formation was demonstrated by analysis of CT data; however, bone resorption was noted in all 3 cases on the 12-month CT scan. The lack of rigidity of the construct in an environment with continuous pulsatile movement may be preventing the formation of solid bone. It is possible to produce a customized allogeneic MSC construct for cranial reconstruction to replace cranial bone with good cosmesis, using a combination of medical computer modelling, rapid-prototyping and tissue engineering.

KW - allogeneic cells

KW - clinical trial

KW - cranial reconstruction

KW - cranioplasty

KW - mesenchymal stromal cells

KW - tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=85042097754&partnerID=8YFLogxK

U2 - 10.1002/term.2459

DO - 10.1002/term.2459

M3 - Article

VL - 12

SP - 341

EP - 348

JO - Journal of Tissue Engineering and Regenerative Medicine

JF - Journal of Tissue Engineering and Regenerative Medicine

SN - 1932-6254

IS - 2

ER -